This research reports a highly resistant Enterobacter hormaechei isolate co-harbouring multiple carbapenemases, highlighting potential treatment challenges.
Background Carbapenem-resistant Enterobacterales (CRE) frequently cause serious, life-threatening infections with limited treatment options. The most common mechanism of carbapenem resistance is carbapenemase production. Colombia is considered endemic for KPC, while metallo-β-lactamases such as NDM and VIM are increasingly circulating. An emerging concern is the appearance of strains harbouring more than one carbapenemase. Here, we report a sentinel Enterobacter hormaechei isolate, highly resistant to β-lactams and co-harbouring three carbapenemases. Methods Enterobacter hormaechei was isolated from the wound of a 22-year-old male and molecularly characterized to decipher its resistance profile. Multiplex real-time PCR was used to screen for carbapenemases. Long-read WGS was performed using ONT MinION™, the genome was assembled de novo and resistome and plasmid types were analysed. Conjugation experiments were performed using E. coli J53-AzR as a recipient. Results Multiplex PCR revealed the presence of blaKPC, blaVIM, and blaNDM. Conjugation experiments yielded blaKPC, and blaKPC-blaVIM-blaNDM transconjugants, suggesting two distinct plasmids. WGS confirmed that blaKPC-2 was encoded on a 58 Kb IncN plasmid, while blaVIM-24 and blaNDM-1 were carried by a 370 Kb multi-replicon plasmid (IncR-IncFII-IncC). Conclusions Although the emergence of triple-carbapenemase producers has been reported, it remains rare. However, sentinel isolates as the one described here (KPC-VIM-NDM) are extremely worrisome since dissemination of multiple carbapenemases could occur via conjugative plasmids in addition to horizontal gene transmission via mobile genetic elements. Considering that Colombia has long been considered a KPC-endemic country, the findings described here call for a thorough epidemiological surveillance to assess the real frequency of Enterobacterales carrying multiple carbapenemases.
No takes yet. Share an insight, caveat, or question.
Rojas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: